Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.410, 2003-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost savings with CAD DM programme in the US
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 348, 2002-01 ,pp. :
Palivizumab pharmacy programme cost saving in the US
Inpharma, Vol. 1, Iss. 1410, 2003-01 ,pp. :
Broad coverage DM programme cost saving in first year
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 435, 2003-01 ,pp. :
Ciprofloxacin stepdown programme cost saving
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 282, 2000-01 ,pp. :
CHF DM programme prolongs survival but no cost savings
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 469, 2005-01 ,pp. :